Search results
Tyrvaya side effects: What they are and how to manage them
Medical News Today· 6 days agoTyrvaya is a prescription drug to treat dry eye disease. Learn about the common, mild, and serious...
Skye Bioscience to stop eye disease drug development after failing mid-stage study
Reuters via Yahoo News· 2 days agoIn the 56-subject study, the eye drop, SBI-100, failed to significantly lower eye pressure in patients with primary open-angle glaucoma when compared with the placebo, the company said. In this ...
A look at various eye diseases and the role of prescription sunglasses
The Times of Northwest Indiana· 5 days agoContributor content. Prescription sunglasses, especially those with polarized lenses, can be...
Do eye exercises and blue-light blocking glasses actually work? An expert explains | CNN
CNN.com· 2 days agoCNN is showcasing the work of The Conversation, a collaboration between journalists and academics to...
The life-saving health tests every middle-aged man should have even if they hate the doctor
The Telegraph via Yahoo News· 15 hours agoMen die four to six years younger than women on average, according to government figures. Alongside...
Skye Bioscience ends eye disease R&D efforts after glaucoma drug’s phase 2 fail
FierceBiotech· 2 days agoSkye Bioscience’s share price tumbled in pre-market trading Monday, as the biotech announced a...
Skye Bioscience to stop eye disease drug development after failing mid-stage study
Reuters· 2 days ago, opens new tab said on Monday it would discontinue development of its experimental eye disease treatment after the drug failed to meet the main goal of ...
Viridian shares hold as RBC maintains $35 target By Investing.com
Investing.com· 12 hours agoOn Tuesday, RBC (TSX:RY) Capital maintained its positive stance on Viridian Therapeutics...
Macular Telangiectasia Type 2 (MacTel2) and Vision Loss
Verywell Health via Yahoo News· 6 days agoVision loss has many potential causes, so getting an accurate diagnosis is a key factor in getting...
Novartis, Roche, Biogen and Samsung Bioepis in Italy Eye-Medicine Probe
Morningstar· 6 days agoItaly's competition watchdog is investigating four pharmaceutical companies over what it called coordination of their commercial strategies, allegedly delaying access to a biosimilar